VR Logo

Second Sight Medical Products Inc. (EYES) download report


Healthcare | Medical Devices & Equipment

Second Sight Medical Products Inc. (EYES) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals.

IPO Date: 19-Nov-2014

Acting Chief Exec. Officer: Mr. Scott Dunbar

Acting Chief Accounting Officer, Principal Financial Officer & Controller: Mr. Edward Jonathon Sedo

Listing: NASDAQ: EYES

Country: United States

Headquarters: Sylmar, CA

Website: https://www.secondsight.com

Key Facts

Market cap: $82.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-8.29 Mln

Cash: $59.60 Mln

Total Debt: $0.20 Mln

Insider's Holding: 28.61%

Liquidity: Low

52 Week range: $1.14 - 5.28

Shares outstanding: 39,409,200

10 Years Aggregate:

  • CFO: $-202.86 Mln
  • EBITDA: $-217.39 Mln
  • Net Profit: $-239.74 Mln

Stock Performance

Time Period Second Sight Medical Products (EYES) S&P BSE Sensex S&P Small-Cap 600
YTD24.54-9.18-19.12
1 month-6.67-4.78-8.39
3 months41.96-9.66-14.02
1 Year-58.910.81-17.54
3 Years-31.8210.335.95
5 Years-27.4211.345.78
10 Years--11.749.79
As on 01-Jul-2022
Year Second Sight Medical Products (EYES) S&P Small-Cap 600 S&P BSE Sensex
2021-12.8325.2721.99
2020-68.509.5715.75
2019-16.2120.8614.38
2018-53.44-9.705.87
2017-3.0511.7327.91
2016-66.5524.741.95
2015-42.59-3.36-5.03